Read more at MarketWatch.
Teva Pharmaceutical’s stock climbs as schizophrenia treatment shows promise
Date: |
Sort by
Filter
Date
Items per page
-
Potential new drug for menopause shows promise, study shows
In clinical trials, a new drug showed promising results in controlling hot flashes associated with menopause and in improving sleep and overall quality of life. Some who took part in trials of the drug reported life-changing results. NBC News' ...NBC News - Top stories -
Roche Climbs After Weight-Loss Drug Shows Efficacy
Roche Holding said its weight-loss drug candidate achieved positive results in an early-stage trial, giving the company a boost in its bid to catch up to Novo Nordisk and Eli Lilly in a class of medicines that has shaken up everything from pharma ...The Wall Street Journal - Business -
Roche says weight loss drug shows promising results in early trial
The weekly injection helped patients with obesity lose 18.8% of their weight relative to those who received a placebo, after 24 weeks in the phase one trial.CNBC - Business -
Reddit shares climb on ChatGPT deal with OpenAI
Shares of Reddit Inc. rose about 12% in extended trading Thursday after the social-media platform announced a partnership with OpenAI.MarketWatch - Business -
Messi's napkin contract promise sells for £762,400
The napkin on which 13-year-old Lionel Messi's first Barcelona contract was signed is sold at auction - for £762,400.BBC News - Top stories -
China promises 'friendship' as two warships dock in Cambodia
Two Chinese warships docked Sunday at a commercial port in Cambodia, in preparation for joint naval exercises between the two countries.NBC News - Top stories - China -
Biogen and Ionis Pharma shares slide as they end development of ALS treatment
The move comes after early-stage trial failed to result in a clear signal it slowed the disease process.MarketWatch - Business -
FDA approves Amgen's treatment for most deadly form of lung cancer
The FDA cleared the Amgen drug, called Imdelltra, as a treatment for patients with advanced small-cell lung cancer.CNBC - Business - FDA -
Amgen gets FDA approval for small-cell lung-cancer treatment
Amgen on Thursday received approval from U.S. regulators for its drug to treat a form of late-stage lung-cancer.MarketWatch - Business - FDA -
Tesla must climb ‘Mount Everest’ to win shareholder vote, chair warns
FT Exclusive: Robyn Denholm outlines stakes for carmaker and says the idea she is too close to Elon Musk is ‘crap’Financial Times - Business - Tesla
More from MarketWatch
-
Gen Z knows it has a debt problem — and it’s getting help for it
“Instead of suffering in silence or going purely self-help,” younger people in debt “are looking into their options and talking to people,” one expert said.MarketWatch - Business -
Teslas are cheaper than ever. Here’s how Biden’s China tariffs will affect costs.
The Biden administration this week slapped stiff tariffs on Chinese electric vehicles, as well as batteries and battery parts from China.MarketWatch - Business - China -
Talk about a market cap: ‘Dow 40,000’ hats are hot sellers
There’s a market for headwear tied to the stock market.MarketWatch - Business -
Stocks may rise into the summer. These 3 risks could derail the rally.
Given how stocks have reacted to the latest flurry of mixed economic data, a summertime rally feels almost inevitable. Still, investors would be remiss not to consider the myriad risks that could possibly derail it.MarketWatch - Business -
The biggest earnings heavy hitter reports this week, and so do Target and other retailers
Blowout results for Nvidia Corp., the S&P 500 Index’s biggest profit driver, have become part of the ritual when the chip maker reports quarterly results.MarketWatch - Business